Lenalidomide and Rituximab Combination Displays Promise for the Treatment of Patients with Mantle Cell Lymphoma

Investigators from around the world are taking notice of our results in treating patients with mantle cell lymphoma. (MCL) In the below video, Dr. Laurie Sehn from the University of British Columbia shares her thoughts on Dr. Jia Ruan’s clinical trial of lenalidomide plus rituximab for previously untreated mantle cell lymphoma.

 

 

In the following video Dr. Ruan further discusses results of her trial with lenalidomide and rituximab combination for patients with MCL.

Research Collaborators at WCMC

Visit our research collaborators page to learn more about some of the Lymphoma Program’s close internal research collaborators at Weill Cornell Medical College.

Patient Experience at Weill Cornell Medical College Continued

Adam is a young man who was diagnosed with stage 4 Burkitt’s lymphoma and came to the Lymphoma Program at Weill Cornell Medical College for care.